- Research Article
- 10.17816/pmj4315-20
Post-COVOID pathomorphosis (nosomorphosis) of chronic dermatoses. Literature review and clinical case reports
- Mar 03, 2026
- Perm Medical Journal
- T G Sedova + 2 more +2
The COVID-19 pandemic has significantly influenced the course and clinical presentation of skin diseases. Literature data indicate frequent lesions of the mucous membranes, skin, and its adnexa following the novel coronavirus infection caused by SARS-CoV-2. The proportion of dermatoses associated with COVID-19 among infected patients reaches 20.4 %. Based on the time of their development, skin lesions associated with coronavirus infection, are classified as early (acute), observed, within 2 to 4 weeks. These include cutaneous angiitis, morbilliform, papulosquamous, and papulovesicular rashes, drug eruptions, urticaria, and factitial lesions. These dermatoses result from the direct effect of SARS-CoV-2, its toxins and metabolites on the skin and mucous membranes and/or from a concomitant drug-induced toxic-allergic reaction. Late (chronic) skin lesions develop from 1 month to 1 year after novel coronavirus infection or within 4 weeks after vaccination. Late skin diseases exacerbated by SARS-CoV-2 include papulosquamous dermatoses, post-COVID alopecia, allergic dermatoses, collagen vascular diseases, acneiform dermatoses, nail plate changes, erythema, bullous dermatoses, and psychogenic dermatoses. The pathological effect of SARS-CoV-2 in the late stages post-infection or post-vaccination is due to the affinity of certain keratinocyte structures for the virus. The virus enters the cell, stimulates T-lymphocyte activation, enhances T-helper cell proliferation, and hyperproduction of proinflammatory cytokines and antibodies. This leads to interleukins synthesis and hyperstimulation of tissue inflammation, impairing skin cell differentiation. A significant proportion of concomitant dermatoses and comorbid pathologies has been identified in patients with late skin lesions that developed within 1 year after SARS-CoV-2 or within 4 weeks after vaccination. Moderate to severe courses of post-COVID dermatoses and complicated clinical cases have been frequently reported. Most clinical observations have shown a predominance of widespread rashes, atypical localization, and atypical clinical presentations, with rare clinical variants being more common. Combinations of two and three dermatological nosologies in a single patient (multimorbidity) have been noted. Pathomorphosis (nosomorphosis) of papulosquamous and autoimmune skin diseases has been observed, manifesting as the evolution of one dermatosis into another.
Read more